Junshengtai Pharmaceutical-B (02511) had a total market value of HK$287 million, of which shareholders deposited 52.601 million shares with CITIC Securities Broker Hong Kong

The Zhitong Finance App learned that according to the latest data from the Hong Kong Stock Exchange, on August 7, Junshengtai Pharmaceutical-B (02511) had a position change, with a total market value of HK$287 million, accounting for 14.73%. The company's shareholders deposited 52.601 million shares in CITIC Securities Brokerage Hong Kong, increasing their shareholding ratio by 5.57%.

According to Junshengtai Pharmaceutical's results for the year ended December 31, 2025, the group obtained additional revenue of 19.07 million yuan, a year-on-year decrease of 72.04%; the company's owners should have accounted for a loss of 245 million yuan, a year-on-year decrease of 35.84%; and a loss of 0.51 yuan per share.